1. Introduction {#sec1-molecules-25-01582}
===============

Medicinal plants and their constituents have countless biological properties, based mainly on their ability to interact with key enzymes linked to several ailments, including: cancer, diabetes, inflammation, hypertension and Alzheimer's disease \[[@B1-molecules-25-01582],[@B2-molecules-25-01582],[@B3-molecules-25-01582],[@B4-molecules-25-01582],[@B5-molecules-25-01582]\]. Recently, EOs have caught the attention of scientists due to their ability to prevent and treat cancer, as well as their state-of-the-art application in the most advanced and sophisticated technologies in nanoscience \[[@B6-molecules-25-01582],[@B7-molecules-25-01582],[@B8-molecules-25-01582]\].

The genus *Achillea* includes over a hundred species and subspecies, which are distributed in the Northern hemisphere \[[@B9-molecules-25-01582]\]. The use of the inflorescence, as well as the whole plant, of many of these species has a long-established role in folk medicine to treat a wide range of ailments that mainly affect the digestive system. It takes various application forms, which differ depending on the geographical area \[[@B10-molecules-25-01582],[@B11-molecules-25-01582],[@B12-molecules-25-01582],[@B13-molecules-25-01582]\]. Besides their medicinal properties, some *Achillea* species are also cultivated as ornamental plants.

*A. membranacea* (Labill.) DC. is one of the six species reported in Jordan \[[@B14-molecules-25-01582]\]: it is distributed in the Irano-Turanian phytogeographic region, which includes Jordan, Palestine, Syria, Lebanon, Iraq and Turkey \[[@B15-molecules-25-01582]\]. *A. membranacea* is a perennial herb. It has numerous stems (25--50 cm), is lignified in the basal section, exhibits pannose, linear, sessile and pinnatisect (1.5--6 cm × 0.3--0.6 cm) leaves, and has a capitula up to 20 mm and yellow ray florets \[[@B15-molecules-25-01582]\].

The EO of many *Achillea* species possesses several biological and pharmacological activities. It is antimicrobial, antimalarial, insecticidal, phytotoxic, anti-inflammatory and antihemorrhoidal \[[@B16-molecules-25-01582],[@B17-molecules-25-01582],[@B18-molecules-25-01582],[@B19-molecules-25-01582],[@B20-molecules-25-01582]\]. Anticancer and cytotoxic effects were reported for the extracts of some *Achillea* species, including *A. clavennae* L. and *A. millefolium* L., the iso-seco-guaianolide, which was isolated from *A. clavennae* L., exhibited potent antiproliferative and apoptotic effects on U251 and glioma cell lines, with a potency comparable to that of cisplatin \[[@B21-molecules-25-01582]\], mediated by its oxidative and mitotic activities. Another compound, casticin, showed multiple antitumor activities. Casticin, which was isolated from *A. millefolium* L. through HPLC, showed cytotoxic, early apoptosis, G~2~/M cell cycle arrest and consequently disruption of the mitotic spindle in two MCF7 sublines \[[@B22-molecules-25-01582]\]. In a previous study, the methanol extract of *A. membranacea* exerted a moderate cytotoxic effect upon Jurkat cells (T-cell leukemia) using the MTT assay \[[@B23-molecules-25-01582]\].

As a part of an ongoing research program on the Middle Eastern plants bioactivity \[[@B24-molecules-25-01582]\], we have selected *A. membranacea* for this study with the aim to analyze the composition of the EO of *A. membranacea* collected in Jordan and to evaluate its cytotoxic activity against breast (MCF7), ovary (A2780) and colon (HT29) cancer cell lines, and non-tumorigenic human fetal lung fibroblasts (MRC5 cells). Moreover, its effects on apoptosis and cell cycle effect of the EO on A2780 cells were investigated. Beside the EO, we have tested the cytotoxicity, induction of apoptosis and cell cycle effect of its major constituent, 1,8-cineole, against A2780 cell line, disclosing the possible action mechanism of the EO and its major constituent.

2. Results {#sec2-molecules-25-01582}
==========

2.1. A. membranacea Essential Oil Composition {#sec2dot1-molecules-25-01582}
---------------------------------------------

The complete composition of the essential oil (EO) hydrodistilled from *A. membranacea* aerial parts is reported in [Table 1](#molecules-25-01582-t001){ref-type="table"}. A total of 96 compounds were identified, accounting for 92.0% of the total composition, which was chiefly made up of monoterpenes. In particular, over 45% of the total was constituted by oxygenated monoterpenes, of which 1,8-cineole was the most represented: exhibiting a relative abundance of 21.7%, it was also the most abundant compound in the EO. Other quantitatively relevant compounds of this chemical class were borneol and *trans*-pinocarveol, whose relative concentrations were 4.3% and 3.1%, respectively. Non-terpene derivatives accounted for up to 22.4%, making them the second most abundant detected chemical class of compounds in the EO. Among them, aldehydes prevailed (12.7%), with decanal and (*Z*)-4-decenal being the most abundant; hydrocarbons followed, accounting for up to 5.0%. Sesquiterpenes were almost equally represented by their hydrocarbon and oxygenated forms (6.7% and 6.9%, respectively). Among the former, α-cadinene was the most represented, while spathulenol was the most abundant of the latter class. Apocarotenes and phenylpropanoids followed, with relative concentrations of 4.2% and 3.9%, respectively.

2.2. Cytotoxic Activity {#sec2dot2-molecules-25-01582}
-----------------------

The cytotoxic activity of *A. membranacea* EO against the tested cell lines is reported in [Table 2](#molecules-25-01582-t002){ref-type="table"}. It induced significant growth inhibition in ovarian (A2780) and colorectal (HT29) cells (IC~50~ = 12.99 and 14.02 μg/mL, respectively). Negligible toxicity was noticed, however, in treated breast cancer (MCF7) and human fetal lung fibroblast (MRC5) cells (IC~50~ = 50.86 μg/mL and IC~50~ = 49.25 μg/mL, respectively). The EO was four times more selective for A2780 and HT29 cell lines compared to MRC5 cells (IC~50~ = 49.25 μg/mL). The major component, 1,8-cineole, was selected for further cytotoxicity assessments. 1,8-Cineole showed remarkable cytotoxicity compared to *A. membranacea* EO in A2780 cells (0.26 μM); its selectivity was 42 times higher for A2780 compared to MRC5 cells (10.5 μM). Using the same cell lines, the selectivity profile of 1,8-cineole was better compared to doxorubicin, as the latter showed only a twofold improvement in selectivity ([Table 3](#molecules-25-01582-t003){ref-type="table"}).

2.3. Induction of Cell Apoptosis {#sec2dot3-molecules-25-01582}
--------------------------------

In order to explore the mechanism of action, the induction of apoptosis by *A. membranacea* EO on A2780 cells was investigated at the same time-point of testing the cytotoxicity (72 h) to confirm its apoptotic *vs* necrotic properties. The EO showed a dose-dependent increase of combined early and late apoptosis in A2780 cells, although its effect at the 25 and 50 µg/mL was close. The EO caused mainly a late apoptosis compared to early apoptosis in A2780 cells. There was also an increase in the necrotic events from 4% to 20% at the three doses ([Figure 1](#molecules-25-01582-f001){ref-type="fig"}A,B). The situation was inverted when 1,8-cineole was used alone in A2780 cells at the same time-point, as it caused a dose-dependent increase in early apoptosis up to 37% at 1 µM, with only 2% late apoptosis and negligible necrotic effect ([Figure 1](#molecules-25-01582-f001){ref-type="fig"}C,D).

2.4. Perturbation of the Cell Cycle {#sec2dot4-molecules-25-01582}
-----------------------------------

The cell-cycle analysis on *A. membranacea* EO treated A2780 cells was performed (72 h), showing a non-dose dependent slight S arrest at 12.5 and 50 μg/mL. Moreover, the EO caused a 10% increase in the preG1 at the expense of G~1~ and G~2~/M decreased events ([Figure 2](#molecules-25-01582-f002){ref-type="fig"}A,B). 1,8-Cineole also caused S phase arrest only at 12.5 μg/mL, but it induced a 15-20-fold sharp dose dependent increase in the preG~1~ apoptotic events in A2780 cells ([Figure 2](#molecules-25-01582-f002){ref-type="fig"}C,D).

3. Discussion {#sec3-molecules-25-01582}
=============

The main constituent of the *A. membranacea* EO analyzed in this study was 1,8-cineole (over 20% of the total). This monoterpene was also found to be a major constituent of some other *Achillea* spp., such as *A. santolina* L. (syn. of *Achillea tenuifolia* Lam.; 16.7%) \[[@B25-molecules-25-01582]\], *A. tomentosa*L. (56.1%) \[[@B26-molecules-25-01582]\], *A. wilhelmsii* (syn. of *Achillea santolinoides* subsp*. wilhelmsii* (K.Koch) Greuter), *A. thracica* Velen. (7.46%--35.72%) \[[@B27-molecules-25-01582]\] and *A. millefolium* L. (1.2%--19.8%) \[[@B28-molecules-25-01582]\]. Previous studies on 1,8 cineole, or on EOs containing it, reported apoptotic effects on a variety of cancer cell lines, including: SK-MEL-28 (human melanoma); A549 (human lung carcinoma); Colo-205 (Human Caucasian colon adenocarcinoma); (SiHa) cells (human cervical carcinoma); Hep-G2 (hepatocellular carcinoma); MCF-7, T47D, MDA-MB-231 (human breast adenocarcinoma); RKO (Human colon carcinoma); Caco-2 (human Caucasian colon adenocarcinoma); A431 (squamous cell carcinoma); MG-63 (osteosarcoma) and P815 (murine mastocytoma) \[[@B29-molecules-25-01582],[@B30-molecules-25-01582],[@B31-molecules-25-01582],[@B32-molecules-25-01582],[@B33-molecules-25-01582],[@B34-molecules-25-01582],[@B35-molecules-25-01582],[@B36-molecules-25-01582],[@B37-molecules-25-01582]\]. This study has enriched the list of those cancer cell lines susceptible to 1,8-cineole and EO rich in1,8-cineole, and has demonstrated its potent effect on the ovarian cancer cell line (A2780).

In a previous published study, we reported the marginal cytotoxic effect of the methanol extract of the aerial parts of *A. membranacea* on Jukart cells, with an IC~50~ value of 60 ± 5.1 μg/mL \[[@B15-molecules-25-01582]\]. That extract, however, did not exert any cytotoxic effect on MCF7 or A2780 cancer cell lines (IC~50~ \> 200 μg/mL) \[[@B23-molecules-25-01582]\]. The growth of A2780 cells in this study was, however, significantly inhibited (IC~50~ = 12.99 μg/mL) by *A. membranacea* EO, since the natural product components are generally considered cytotoxic when their IC~50~ is ≤ 20 μg/mL \[[@B38-molecules-25-01582]\]. The tested EO resulted in the cytotoxicity of the A2780 cell line, while its effect on MCF7was negligible (IC~50~ = 50.86 μg/mL). In this study, both the EO and 1,8-cineole induced apoptosis in A2780 cells; but 1,8-cineole induced more early apoptosis with minimal late apoptosis and necrosis, compared to a major induction of late apoptosis by the EO at the same time point. The EO also caused 4%--20% necrotic events in A2780 cells compared to control cells, indicating the possible effect of other components. The improved cytotoxic and apoptotic activities of 1,8-cineole compared to *A. membranacea* indicates the possible involvement of one major mechanism of action in *A. membranacea* EO*,* while the substantial difference between the activities of the EO and the methanol extract of the aerial parts could be due to the difference in the constituents of each extract.

Furthermore, the cell cycle perturbation results of the present work were similar to those observed in a previous study conducted on wild-type p53 H460 cells (but not mutant p53 H460 cells) after the treatment with *Achillea millefolium* hydroalcoholic extract \[[@B39-molecules-25-01582]\]. Pereira et al. (2018) demonstrated the induction of apoptosis and S-phase arrest, with an increased level of p53 and p21 indicating the different mechanisms involved in the *Achillea millefolium* extract-induced growth arrest. Likewise, a previous study reported that casticin, a flavonoid extracted from *Achillea millefolium*, caused G~2~/M arrest in HCT116 colon cancer cells, which was confirmed by the induction of p21 and down-regulation of CDK1\[[@B14-molecules-25-01582]\]. However, 1,8 cineole was reported to induce cell cycle arrest in the G~2~/M phase in the HCT116 cell line \[[@B30-molecules-25-01582]\], while the studied *A. membranacea* EO and 1,8 cineole induced preG~1~ increase, which indicate DNA fragmentation and confirm the pro-apoptotic effect in A2780 cells. Further mechanistic studies of the activities of *A. membranacea* components and 1,8 cineole against an array of cancer cell lines are worthwhile, as well as *in vivo* studies, which will provide more support for their application.

4. Materials and Methods {#sec4-molecules-25-01582}
========================

4.1. Plant Material {#sec4dot1-molecules-25-01582}
-------------------

The aerial parts of *A. membranacea* were collected during the spring in the Dab'a desert reserve (50 km South of Amman), Jordan (GPS coordinates: 31° 31' 58" N, 36° 01' 20" E). The plant was identified by Prof. A. Bader. A voucher specimen was deposited in the herbarium of the Pharmacognosy Lab (Number Jo-It 2018/2), at Umm Al-Qura University, Makkah, Saudi Arabia.

4.2. Hydrodistillation of the Essential Oil {#sec4dot2-molecules-25-01582}
-------------------------------------------

The hydrodistillation of *A. membranacea* was performed with a Clevenger-type apparatus equipped with an electric mantle heater (Tecnovetro, Pisa, Italy). A sample (100 g) of air-dried material was hydrodistilled for 3 h. The extraction yield was 0.09 % *w/w*.

4.3. Gas Chromatography--Mass Spectrometry Analyses and Compounds Identification {#sec4dot3-molecules-25-01582}
--------------------------------------------------------------------------------

The hydrodistilled EO of *A. membranacea* was diluted to 5% in HPLC-grade *n*-hexane and then injected into a Varian CP-3800 GC-MS apparatus (GC-EI-MS, Varian, Inc. Palo Alto, CA, USA) equipped with a DB-5 capillary column (30 m × 0.25 mm; coating thickness 0.25 μm) and a Varian Saturn 2000 ion trap mass detector (Varian, Inc. Palo Alto, CA, USA). Analytical conditions were as previously reported \[[@B40-molecules-25-01582]\]. The identification of the constituents was based on the comparison of the retention times with those of authentic samples, comparing their linear retention indices relative to the series of *n*-hydrocarbons, commercial libraries such as NIST 14 and ADAMS and a homemade mass-spectral library of pure compounds were used to compare the mass spectra \[[@B41-molecules-25-01582],[@B42-molecules-25-01582]\].

4.4. Chemicals and Reagents {#sec4dot4-molecules-25-01582}
---------------------------

1,8-Cineole was kindly gifted by Mr. Mohammed Khair Al Halabi, United Tetra Group for Medical and Scientific Supplies, Jordan. Doxorubicin and all reagents were purchased from Sigma--Aldrich, St. Louis, MO, USA.

4.5. Cell Culture {#sec4dot5-molecules-25-01582}
-----------------

Three human cancerous (MCF7, A2780 and HT29) and one fibroblast (MRC5) cell lines were used in this study. Cancer cells were maintained in RPMI-1640, and MRC5 cells were maintained in EMEM media. All media were supplemented with FBS (10%), sodium pyruvate (1 mM), L-glutamine (2 mM) and penicillin/streptomycin (1%). Cell cultures were kept on 5% CO~2~ in humidified incubator at 37 °C.

4.6. Cytotoxicity Assay {#sec4dot6-molecules-25-01582}
-----------------------

Cells were seeded in 96-well plates and exposed to the essential oil of *A. membranacea* at concentrations up to 100 μg/mL for 72 h. 1,8-cineole and doxorubicin concentrations were made up to 50 µM also for 72 h. MTT assay was then performed as previously reported \[[@B43-molecules-25-01582]\]. Absorbances were measured using a multi-plate reader at a wavelength 550 nm. IC~50~ values were determined by calculated the oil concentration-induced 50% reduction in the absorbance compared to untreated control.

4.7. Induction of Apoptosis Assay {#sec4dot7-molecules-25-01582}
---------------------------------

The induction of apoptosis activity of *A. membranacea* EO and 1,8-cineole was investigated by annexin V FITC/Propidium iodide protocol as described in the literature \[[@B44-molecules-25-01582]\]. Briefly, A2780 cells were seeded at 1 × 10^5^ cells/well in 6-well plate overnight before treatment with either *A. membranacea* EO or 1,8-cineole at four concentrations, ranging from 0 to 50 μg/mL, or 0--1 µM, respectively (representing IC~50~: 0, ×1, ×2 and ×4). Following treatment, cells were collected (including the supernatant), washed with ice-cold PBS and then incubated for 2 min in binding buffer (100 µL) and annexin V FITC (10 μL), at room temperature in the dark. Additional 400 μL of binding buffer and 10 μL PI were then added. The early apoptotic, late apoptotic, and necrotic cell populations were analyzed by flow cytometry (FC500, Beckman Coulter, Brea, CA, USA), based on 20,000 events per sample.

4.8. Perturbation of the Cell Cycle {#sec4dot8-molecules-25-01582}
-----------------------------------

A2780 cells were seeded at 1 × 10^5^ cells/well in 6-wellplate overnight before being treated with either *A. membranacea* or 1,8-cineole essential oils at four concentrations ranged from 0 to 50 μg/mL, or 0 to 1 µM, respectively. Cells were then suspended by trypsin-EDTA and spun at 200× *g* for 5 min. Collected cell pellets were washed in ice-cold PBS before they were fixed in 70% ice-cold ethanol overnight. The cell cycle analysis was then performed and analyzed for 20,000 events per sample, using flow cytometry (FC500, BC, USA), following the protocol described elsewhere \[[@B45-molecules-25-01582],[@B46-molecules-25-01582]\].

4.9. Statistical Analysis {#sec4dot9-molecules-25-01582}
-------------------------

Statistical differences of samples, compared to untreated control cells, were assessed by a one-way ANOVA with the Tukey's post-hoc multiple comparison test (GraphPad Prism Version 5, GraphPad Software, San Diego, CA, USA). *p* \< 0.05 (\*), *p* \< 0.01 (\*\*) and *p* \< 0.001 (\*\*\*) were taken as significant.

**Sample Availability:** The starting plant material is available from the authors.
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![Detection of early and late apoptosis in A2780 cells (72 h) treated with *A. membranacea* essential oil (**A**,**B**), and 1,8-cineole (**C**,**D**). Dot histograms (**A**,**C**): x-axis: annexin V, y-axis: propidium iodide. C1: necrotic cells, C2: late apoptotic cells, C3: live cells, C4: early apoptotic cells. Data shown are % mean ± SD (*n* = 3). All experiments were performed three times. Statistical differences, compared to untreated control cells, were assessed by a one-way ANOVA with the Tukey's post-hoc multiple comparison test. *p* \< 0.05 (\*), *p* \< 0.01 (\*\*) and *p* \< 0.001 (\*\*\*) were taken as significant.](molecules-25-01582-g001){#molecules-25-01582-f001}

![Flow cytometry showing the effect of *A. membranacea* EO (**A**,**B**) and 1,8-cineole (**C**,**D**) on cell cycle distribution after 72 h treatment in A2780 cells. A, C: X-axis: DNA content of 20,000 events, y axis: % cell number (*n* = 3, experiments were repeated 3×). Statistical differences, compared to untreated control cells, were assessed by a one-way ANOVA with the Tukey's post-hoc multiple comparison test. *p* \< 0.05 (\*), *p* \< 0.01 (\*\*) and *p* \< 0.001 (\*\*\*) were taken as significant.](molecules-25-01582-g002){#molecules-25-01582-f002}

molecules-25-01582-t001_Table 1

###### 

Complete composition of *A. membranacea* essential oil (EO).

  Constituents                     l.r.i.^a^   Relative Abundance (%)
  -------------------------------- ----------- ------------------------
  (*E*)-2-hexenal                  855         1.7
  1-hexanol                        868         0.4
  heptanal                         900         0.4
  (*E*,*E*)-2,4-hexadienal         910         tr ^b^
  α-thujene                        931         tr
  α-pinene                         939         0.7
  camphene                         953         tr
  (*Z*)-2-heptenal                 959         0.2
  benzaldehyde                     961         0.8
  1-heptanol                       969         tr
  sabinene                         976         tr
  1-octen-3-ol                     978         0.2
  6-methyl-5-hepten-2-one          985         0.7
  2,3-dehydro-1,8-cineole          991         1.3
  octanal                          1002        1.6
  α-phellandrene                   1005        0.4
  (*E*,*E*)-2,4-heptadienal        1015        0.4
  α-terpinene                      1018        0.2
  *p*-cymene                       1027        0.3
  1,8-cineole                      1035        21.7
  (*Z*)-β-ocimene                  1041        tr
  3-octen-2-one                    1042        tr
  phenyl acetaldehyde              1045        1.5
  (*E*,*E*)-3,5-octadien-2-one     1090        0.4
  linalool                         1099        1.1
  α-thujone                        1102        2.3
  *cis*-*p*-menth-2-en-1-ol        1123        2
  α-campholenal                    1127        tr
  *cis*-*p*-mentha-2,8-dien-1-ol   1139        tr
  *trans*-pinocarveol              1140        3.1
  camphor                          1145        1.6
  (*E*)-2-nonenal                  1162        0.7
  pinocarvone                      1164        1.0
  borneol                          1166        4.3
  4-terpineol                      1178        0.9
  *p*-cymen-8-ol                   1185        0.3
  cryptone                         1186        tr
  α-terpineol                      1190        1.4
  (*Z*)-4-decenal                  1194        2.2
  myrtenal                         1195        0.8
  safranal                         1200        0.4
  decanal                          1205        2.5
  *trans*-carveol                  1219        tr
  β-cyclocitral                    1223        0.3
  isobornyl formate                1233        0.3
  piperitone                       1254        2.1
  linalyl acetate                  1258        0.7
  *cis*-chrysanthenyl acetate      1263        tr
  geranial                         1272        tr
  isobornyl acetate                1286        0.3
  thymol                           1291        0.3
  carvacrol                        1300        0.4
  (*E*,*E*)-2,4-decadienal         1316        0.2
  methyl decanoate                 1326        tr
  hexyl tiglate                    1333        0.7
  *trans*-piperitol acetate        1346        tr
  α-terpinyl acetate               1351        tr
  eugenol                          1358        tr
  neryl acetate                    1367        tr
  α-copaene                        1376        tr
  (*E*)-β-damascenone              1382        0.9
  *n*-tetradecane                  1400        0.2
  methyl eugenol                   1403        tr
  dodecanal                        1408        tr
  β-caryophyllene                  1418        0.4
  (*E*)-α-ionone                   1428        0.3
  cabreuva oxide A                 1447        tr
  (*E*)-geranyl acetone            1454        1.7
  β-santalene                      1462        1.2
  cabreuva oxide D                 1480        0.8
  germacrene D                     1485        0.9
  (*E*)-β-ionone                   1485        0.6
  *cis*-β-guaiene                  1492        0.9
  bicyclogermacrene                1494        0.4
  *n*-pentadecane                  1500        tr
  tridecanal                       1518        0.3
  myristicin                       1520        3.3
  7-*epi*-a-selinene               1522        0.3
  α-cadinene                       1538        2.6
  ledol                            1565        0.3
  *trans*-nerolidol                1566        0.5
  spathulenol                      1576        2.7
  caryophyllene oxide              1581        0.8
  *n*-hexadecane                   1600        0.4
  β-oplopenone                     1606        0.4
  dill apiole                      1621        0.6
  τ-cadinol                        1641        0.4
  β-eudesmol                       1649        0.7
  intermedeol                      1667        0.3
  *n*-heptadecane                  1700        tr
  pentadecanal                     1717        0.2
  hexahydrofarnesylacetone         1845        tr
  (3*Z*)-cembrene A                1959        0.4
  linoleic acid ethyl ester        2160        2.3
  1-pentacosene                    2400        3.8
  *n*-pentacosane                  2500        0.6
  Monoterpene hydrocarbons         1.6         
  Oxygenated monoterpenes          45.9        
  Sesquiterpene hydrocarbons       6.7         
  Oxygenated sesquiterpenes        6.9         
  Diterpene hydrocarbons           0.4         
  Apocarotenes                     4.2         
  Phenylpropanoids                 3.9         
  Other non-terpene derivatives    22.4        
  Total identified (%)             92.0        

^a^ Linear retention indices on a DB-5 capillary column; ^b^ Traces, \< 0.1%.

molecules-25-01582-t002_Table 2

###### 

Cytotoxic activity of *A. membranacea* essential oil against three cancer cell lines and one normal fibroblast (MTT 72 h, IC~50~ ± SD μg/mL).

  MCF7            A2780          HT29           MRC5
  --------------- -------------- -------------- --------------
  50.86 ± 10.14   12.99 ± 2.96   14.02 ± 4.89   49.25 ± 1.27

molecules-25-01582-t003_Table 3

###### 

Cytotoxic activity of 1,8-cineole and doxorubicin against A2780 and MRC5 cells (MTT 72 h, IC~50~ ± SD μM)**.**

                A2780         MRC5
  ------------- ------------- --------------
  1,8-Cineole   0.26 ± 0.04   10.50 ± 1.70
  doxorubicin   0.14 ± 0.02   0.21 ± 0.03
